Compare Figma Inc. Class A Common Stock (FIG) vs Heron Therapeutics Inc (HRTX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Figma Inc. Class A Common Stock vs Heron Therapeutics Inc — how do they compare? Figma Inc. Class A Common Stock trades at $21.26 (market cap $11.60B), while Heron Therapeutics Inc trades at $0.36 (market cap $74.18M). The key difference: Figma Inc. Class A Common Stock is far larger — about 156.4× Heron Therapeutics Inc's market cap, and Figma Inc. Class A Common Stock is more actively traded (12,281,013 versus 1,857,401). Which is the better fit depends on your goals — on Pluang, investors hold Figma Inc. Class A Common Stock for 0 Days and Heron Therapeutics Inc for 36 Days on average.
| FIG | HRTX | |
|---|---|---|
Market Cap | $11.60B | $74.18M |
Volume | 12,281,013 | 1,857,401 |
Sector | Technology | Health |
52-Week High | $63.82 | $1.49 |
52-Week Low | $16.84 | $0.27 |
Typical Hold Time | 0 Days | 36 Days |
Enterprise Value | $10.00B | $180.92M |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
HRTX trades at $0.3906, down 6.02% today, with a bullish technical signal from moving averages and oscillators. The company reported Q2 2026 revenue of $37.7 million but missed EPS estimates. Despite a high gross margin of 70.07%, it posted a net loss of -$20.20 million in 2025. Analyst consensus is strongly positive with 17 buy ratings. Recent news highlights earnings results and competitive comparisons.
The outlook remains speculative given persistent losses and negative ROE, but strong analyst support and improving cash flow trends offer potential upside. Key risks include profitability challenges and revenue volatility. Investors should weigh the bullish sentiment against fundamental weaknesses.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Figma Inc. Class A Common Stock
Figma, Inc. is a US software company that operates a collaborative interface design and product development platform used by design and engineering teams to create, prototype, and build digital products.
Read more on FIG →About Heron Therapeutics Inc
Heron Therapeutics is a commercial-stage biotechnology company focused on improving patient care. It develops best-in-class medicines for pain management and cancer care to address unmet medical needs.
Read more on HRTX →
